FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007069182> ?p ?o ?g. }

• W2007069182 endingPage "67" @default.
• W2007069182 startingPage "62" @default.
• W2007069182 abstract "The use of antiplatelet and antithrombotic agents after peripheral vascular interventions is a common clinical practice despite a lack of clear convincing evidence or accepted practice guidelines. The goal of this study was to assess surgeons' prescribing practices after endovascular procedures for lower extremity arterial occlusive disease.Attendees at a national vascular meeting were asked to complete a voluntary survey indicating their prescribing practices of antiplatelet/antithrombotic agents for the following procedures: iliac bare-metal stent, iliac covered stent, infrainguinal balloon angioplasty, infrainguinal bare-metal stent, infrainguinal covered stent, infrainguinal atherectomy, and lower extremity cryoplasty. The respondents were given choices of aspirin (ASA) alone, clopidogrel alone, ASA/clopidogrel combined, warfarin alone, or ASA/clopidogrel/warfarin combined. They were also asked to indicate their preferred length of treatment for each medication or combination of medications for each procedure: 1, 3, 6, or 12 months.There were 51 respondents (48 vascular surgeons and 3 vascular fellows) with an average of 11 ± 6.4 years of experience and practicing in a university hospital (48%), community hospital (44%), or combined university/Veterans A hospital (6%) setting. The majority of respondents (98%) prescribe an antiplatelet agent for patients with peripheral arterial disease using 81 mg of ASA preferentially. Most surgeons do not obtain genetic testing (i.e., cytochrome P450, polypeptide 19 [CYP2C19] polymorphism) for antiplatelet effectiveness. The most common antiplatelet/antithrombotic medication of choice after lower extremity endoluminal therapy was a combination of ASA/clopidogrel. However, the duration of medical treatment was variable, with a 1- to 3-month course being the most common. The use of the ASA/clopidogrel combination increased with further distal endovascular treatment and the placement of stents versus angioplasty. In the vast majority of ASA-only responses, ASA was administered for at least 12 months if not recommended for life. Although the majority of surgeons would recommend dual antiplatelet therapy (52-77%), there was no consensus regarding the duration of treatment.The antiplatelet/antithrombotic prescribing practices of vascular surgeons after lower extremity endovascular procedures are highly variable. Multicenter randomized controlled trials are needed to define optimal treatment efficacy and define the much-needed practice guidelines." @default.
• W2007069182 created "2016-06-24" @default.
• W2007069182 creator A5026274935 @default.
• W2007069182 creator A5027059295 @default.
• W2007069182 creator A5040420566 @default.
• W2007069182 creator A5060999104 @default.
• W2007069182 creator A5069311727 @default.
• W2007069182 date "2013-01-01" @default.
• W2007069182 modified "2023-09-24" @default.
• W2007069182 title "Prescribing Patterns of Antiplatelet Agents Are Highly Variable After Lower Extremity Endovascular Procedures" @default.
• W2007069182 cites W1975555310 @default.
• W2007069182 cites W2022554332 @default.
• W2007069182 cites W2023147805 @default.
• W2007069182 cites W2033703944 @default.
• W2007069182 cites W2033856590 @default.
• W2007069182 cites W2037500444 @default.
• W2007069182 cites W2038552179 @default.
• W2007069182 cites W2053379248 @default.
• W2007069182 cites W2079595856 @default.
• W2007069182 cites W2084673482 @default.
• W2007069182 cites W2085044439 @default.
• W2007069182 cites W2122523807 @default.
• W2007069182 cites W2151078548 @default.
• W2007069182 cites W2167067204 @default.
• W2007069182 cites W2314922794 @default.
• W2007069182 cites W311320695 @default.
• W2007069182 cites W4376848313 @default.
• W2007069182 doi "https://doi.org/10.1016/j.avsg.2012.05.001" @default.
• W2007069182 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22981017" @default.
• W2007069182 hasPublicationYear "2013" @default.
• W2007069182 type Work @default.
• W2007069182 sameAs 2007069182 @default.
• W2007069182 citedByCount "34" @default.
• W2007069182 countsByYear W20070691822013 @default.
• W2007069182 countsByYear W20070691822014 @default.
• W2007069182 countsByYear W20070691822015 @default.
• W2007069182 countsByYear W20070691822016 @default.
• W2007069182 countsByYear W20070691822017 @default.
• W2007069182 countsByYear W20070691822018 @default.
• W2007069182 countsByYear W20070691822019 @default.
• W2007069182 countsByYear W20070691822020 @default.
• W2007069182 countsByYear W20070691822021 @default.
• W2007069182 countsByYear W20070691822022 @default.
• W2007069182 crossrefType "journal-article" @default.
• W2007069182 hasAuthorship W2007069182A5026274935 @default.
• W2007069182 hasAuthorship W2007069182A5027059295 @default.
• W2007069182 hasAuthorship W2007069182A5040420566 @default.
• W2007069182 hasAuthorship W2007069182A5060999104 @default.
• W2007069182 hasAuthorship W2007069182A5069311727 @default.
• W2007069182 hasConcept C126322002 @default.
• W2007069182 hasConcept C141071460 @default.
• W2007069182 hasConcept C2776301958 @default.
• W2007069182 hasConcept C2777010666 @default.
• W2007069182 hasConcept C2777015399 @default.
• W2007069182 hasConcept C2777265216 @default.
• W2007069182 hasConcept C2777628954 @default.
• W2007069182 hasConcept C2777849778 @default.
• W2007069182 hasConcept C2778583881 @default.
• W2007069182 hasConcept C2778789114 @default.
• W2007069182 hasConcept C2778905298 @default.
• W2007069182 hasConcept C2779161974 @default.
• W2007069182 hasConcept C2780326628 @default.
• W2007069182 hasConcept C2909112448 @default.
• W2007069182 hasConcept C71924100 @default.
• W2007069182 hasConceptScore W2007069182C126322002 @default.
• W2007069182 hasConceptScore W2007069182C141071460 @default.
• W2007069182 hasConceptScore W2007069182C2776301958 @default.
• W2007069182 hasConceptScore W2007069182C2777010666 @default.
• W2007069182 hasConceptScore W2007069182C2777015399 @default.
• W2007069182 hasConceptScore W2007069182C2777265216 @default.
• W2007069182 hasConceptScore W2007069182C2777628954 @default.
• W2007069182 hasConceptScore W2007069182C2777849778 @default.
• W2007069182 hasConceptScore W2007069182C2778583881 @default.
• W2007069182 hasConceptScore W2007069182C2778789114 @default.
• W2007069182 hasConceptScore W2007069182C2778905298 @default.
• W2007069182 hasConceptScore W2007069182C2779161974 @default.
• W2007069182 hasConceptScore W2007069182C2780326628 @default.
• W2007069182 hasConceptScore W2007069182C2909112448 @default.
• W2007069182 hasConceptScore W2007069182C71924100 @default.
• W2007069182 hasIssue "1" @default.
• W2007069182 hasLocation W20070691821 @default.
• W2007069182 hasLocation W20070691822 @default.
• W2007069182 hasOpenAccess W2007069182 @default.
• W2007069182 hasPrimaryLocation W20070691821 @default.
• W2007069182 hasRelatedWork W1977409210 @default.
• W2007069182 hasRelatedWork W2033835214 @default.
• W2007069182 hasRelatedWork W2147647886 @default.
• W2007069182 hasRelatedWork W2350879373 @default.
• W2007069182 hasRelatedWork W2472318845 @default.
• W2007069182 hasRelatedWork W2888386364 @default.
• W2007069182 hasRelatedWork W3031883134 @default.
• W2007069182 hasRelatedWork W3137208668 @default.
• W2007069182 hasRelatedWork W2023060298 @default.
• W2007069182 hasRelatedWork W2488738102 @default.
• W2007069182 hasVolume "27" @default.
• W2007069182 isParatext "false" @default.
• W2007069182 isRetracted "false" @default.
• W2007069182 magId "2007069182" @default.

• next